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Abstract
The aim of this study was to perform a comprehensive gene
expression analysis of cytokines, chemokines, and their
receptors in Chlamydia trachomatis-infected human monocytes
in order to elucidate molecular aspects of their involvement in
the host response. Peripheral blood mononuclear cells from
three healthy donors were separated and infected with C.
trachomatis  elementary bodies serovar K (UW/31/Cx) at a
multiplicity of infection of 5:1. Three time points of infection were
studied by gene expression analysis using microarray: 4 hours
(active infection), 1 day (transition), and 7 days (persistent
infection). Expression levels of selected genes were confirmed
by quantitative real-time reverse transcription-polymerase chain
reaction. Transcripts encoding 10 cytokines, chemokines, and
receptors were found to be upregulated exclusively in the early,
active phase of the infection as compared to four genes in the
late, persistent state of the infection. Apart from receptors, both
the level and the number of transcripts encoding inflammatory
products decreased with ongoing infection. Four genes
(interferon-gamma, macrophage inflammatory protein [MIP]-1-
alpha, MIP-1-beta, and interleukin-2 receptor-gamma) were
constantly expressed over a period of 7 days. The current study
provides data on the induction of mRNA encoding cytokines,
chemokines, and their receptors in C. trachomatis-infected
human monocytes. This pro-inflammatory gene expression
profile of the monocytic host cell showed several differences
between active and persistent chlamydial infections.
Introduction
Reactive arthritis (ReA) is characterized by the presence of
metabolically active bacteria or bacterial macromolecules in
the synovial compartment but microbial pathogens cannot be
cultured from the synovial material. Chlamydia trachomatis, an
obligate intracellular pathogen, is the most common cause of
ReA but only 1% to 3% of patients acquiring infection at the
urogenital tract as the primary site of infection develop
Chlamydia-induced arthritis [1,2]. Chlamydia can generate a
persistent infection during which the normal life cycle is
arrested and aberrant forms are present primarily in mono-
cytes/macrophages in of the synovium and the synovial fluid of
patients with ReA. The molecular mechanisms of chlamydial
persistence are under extensive scrutiny since it is clear that
this phenomenon is the major basis of the arthritis [3]. Several
studies have investigated chlamydial gene expression, com-
paring the active with the persistent infection state. One
remarkable finding was the downregulation of an outer mem-
brane protein (omp1) in persistent infection, possibly account-
ing for the aberrant morphology of persisting Chlamydia. The
1 d pi = 1 day post-infection; 4 h pi = 4 hours post-infection; 7 d pi = 7 days post-infection; EB = elementary body; G3PDH = glyceraldehyde-3-
phosphate dehydrogenase; Hep2 = human larynx carcinoma epithelial cell line; hsp = heat shock protein; IFN-γ = interferon-gamma; IFU = inclusion-
forming units; IgG = immunoglobulin G; IL = interleukin; LIF = leukemia inhibitory factor; LPS = lipopolysaccharide; MCP-1 = monocyte chemotactic 
protein-1; MIP = macrophage inflammatory protein; MOI = multiplicity of infection; omp1 = outer membrane protein; PCR = polymerase chain reac-
tion; pi = post-infection; ReA = reactive arthritis; RT = reverse transcription; RT-PCR = reverse transcription-polymerase chain reaction; SPG = 
sucrose-phosphate-glutamate; TGF-β-1 = transforming growth factor-beta-1; TLR = Toll-like receptor; TNF = tumor necrosis factor; TNFR = tumor 
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upregulation of the heat shock protein (hsp) 60 gene encoding
a highly immunogenic protein might contribute to the inflam-
matory response mounted against persistent Chlamydia
(reviewed in [4]). However, gene expression analyses on the
host response in C. trachomatis-infected human monocytes
are not available yet. This is particularly important because
monocytes/macrophages have been identified as the key cells
involved in microbial dissemination and persistence, having
most likely a pivotal role in the pathogenesis of ReA. We per-
formed a comprehensive analysis of the inflammatory gene
expression profile of C. trachomatis-infected human mono-
cytes over a time course of up to 7 days.
Materials and methods
Chlamydial infection
Blood samples from three healthy donors were used. Periph-
eral blood mononuclear cells were separated according to the
standard Ficoll-Histopaque procedure and incubated in a tis-
sue-culture plate for 20 minutes at room temperature. The non-
adherent cell fraction was carefully removed by washing the
culture plate two times with AIM-V medium (Gibco-Invitrogen
GmbH, Karlsruhe, Germany). The adherent cell fraction con-
tained more than 80% of cells with macrophage-like appear-
ance as determined by inverted microscope and described
earlier [5,6]. C. trachomatis was acquired from the Washing-
ton Research Foundation (Seattle, WA, USA) and multiplied in
the human larynx carcinoma epithelial cell line (Hep2) in RPMI
1640 medium supplemented with 10% heat-inactivated fetal
calf serum (Biochrom AG, Berlin, Germany), 1% (wt/vol) L-
glutamine, and 0.1% (wt/vol) gentamycin. After inoculation for
48 hours, Chlamydia were harvested, purified on a discontin-
uous urographin gradient (Schering, Berlin, Germany) as
described in Caldwell and colleagues [7], resuspended in
sucrose-phosphate-glutamate (SPG) buffer, and finally stored
at -80°C until use.
To determine chlamydial infectivity, sequentially diluted
chlamydial probes were titrated on confluent monolayers of
Hep2 cells. As controls, pure elementary bodies (EBs) at vari-
ous multiplicities of infection (MOIs) were used. Multiple pas-
sages were performed to enhance recovery of released
Chlamydia. After 48 hours, cultures were terminated by the
addition of absolute methanol followed by an indirect immu-
noperoxydase assay (IPAzyme test; medac GmbH, Hamburg,
Germany) for visualization of chlamydial inclusions [8]. For this
purpose, serum of a patient positive for anti-chlamydial anti-
bodies with a specific immunoglobulin G (IgG) titer of 1:1,024
(IPAzyme test) was used. After overnight incubation with the
antibody, the second peroxidase-conjugated goat anti-human
IgG antibody and subsequently 4-chloro-1-naphtol (Savyon
Diagnostics Ltd., Beer Sheva, Israel) were added. Chlamydial
inclusions were identified by light microscopy, and the number
of inclusions was expressed as inclusion-forming units (IFU)
per milliliter of the titrated lysate.
Using 3 × 107 cells per well, monocytes were cultured for 4
hours in six-well plates in RPMI 1640 medium (Invitrogen Cor-
poration) supplemented with 10% human serum, 1% L-
glutamine, and 0.1% gentamycin at 37°C in an atmosphere of
5% CO2 and subsequently inoculated with purified C. tracho-
matis EB serovar K (UW/31/Cx) for 4 hours at an MOI of 5:1.
The chlamydial suspension, which was free of mycoplasma as
determined by polymerase chain reaction (PCR), contained
1.4 × 108 EB IFU per 50 μl.
Unabsorbed Chlamydia were removed 4 hours post-infection
(pi) by washing the plates three times in RPMI growth medium
containing 10% human serum. For recultivation, fresh medium
was added on days 1 and 7. Morphology of monocytes in cul-
ture was monitored microscopically on a daily basis, and their
viability was tested by trypan blue dye exclusion tests on days
1 and 7. At least 80% of infected monocytes were viable on
day 7. The cells were harvested at the three time points men-
tioned below by gently scraping with a rubber policeman.
Samples were stored at -80°C until use. The detailed proce-
dure has been described earlier [9].
To investigate the expression of transcripts encoding inflam-
matory mediators over the time course, the three time points of
4 hours (4 h pi), 1 day (1 d pi), and 7 days (7 d pi) were chosen
because C. trachomatis is known to start replication in mono-
cytes within the first day (early phase of productive cycle, in
this context called 'active' infection) and starts generating a
persistent infection after 24 hours [10-12].
cDNA-based microarray
Messenger RNA of C. trachomatis-infected monocytes of the
three healthy donors was compared with the corresponding
mock-infected samples. For mock infection, SPG buffer was
used instead of the C. trachomatis suspension, and all other
procedures were performed identically. Cells were resus-
pended in solution D, and total RNA was extracted by applica-
tion of phenol/chloroform 5:1 (pH 4.5) (Ambion, Inc., Austin,
TX, USA) followed by precipitation in isopropanol at -80°C for
1 hour and incubation with RQ1 DNase (Promega Corpora-
tion, Madison, WI, USA) at 37°C for 1 hour.
The signal intensity of the glyceraldehyde-3-phosphate dehy-
drogenase (G3PDH) housekeeping gene on the microarray
membrane was used as an indirect quality marker for the RNA
used because only experiments that revealed a G3PDH signal
intensity within 1.5 times the standard deviation of all mem-
branes evaluated in our study were included in the analysis.
The entire microarray procedure and its analysis have been
validated and reported in detail [6]. Total RNA of all donors
was pooled, and for each microarray experiment, 150 μg was
reverse-transcribed and amplified by SMART™-PCR (Clon-
tech, Mountain View, CA, USA), a technology that allows
reverse transcription (RT) of small amounts of total RNA and
subsequent amplification of the entire cDNA. Probes wereAvailable online http://arthritis-research.com/content/9/3/R54
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labeled with phosphorus 32 and subsequently hybridized
overnight to a filter-based nylon membrane containing immobi-
lized cDNA-specific sequences from a total of 1,184 genes
(Human Atlas Array 1.2; BD Biosciences Clontech). For anal-
ysis, we focused solely on the 159 cytokines, chemokines, and
their receptors as given by the manufacturer (see [13] for
detailed information). Signal intensities were retrieved by a
STORM 860 scanner (Molecular Dynamics, now part of GE
Healthcare, Little Chalfont, Buckinghamshire, UK) in combina-
tion with the AtlasImage 2.0 software (Clontech, Mountain
View, CA, USA). Data from all signal intensities were then sub-
tracted by the local background intensity measured around
each gene. The local background intensities of all individual
genes were subsequently averaged, resulting in the mean
background intensity of a particular membrane. Gene expres-
sion in our experiments was determined by a spot intensity of
a single transcript that exceeded twice the mean background.
Normalization to background and to the G3PDH housekeep-
ing gene was achieved by the global (sum) normalization
method. To test the reproducibility of array measurements
between the mock-infected and the C. trachomatis-infected
probes, correlation matrices using Pearson correlation
revealed coefficients of 0.93 (time point 4 h pi), 0.85 (time
point d 1 pi), and 0.91 (time point d 7 pi). The semiquatitative
interpretation (-/+/++/+++) of the differential regulation can
be found in the legends of Tables 1, 2, 3. Signal intensity data
are given as the ratio of C. trachomatis-infected versus mock-
infected probes. The GEO (Gene Expression Omnibus)
accession number is GSE7601.
Quantitative real-time reverse transcription-polymerase 
chain reaction
Expression levels of three of the four genes found to be
expressed at all time points of infection (4 h, 1 d, and 7 d pi)
were selected for RT-PCR measurements as described
previously [9]. Total RNA from C. trachomatis-infected mono-
cytes of five additional healthy donors was used for confirma-
tion of the array data. Again, the corresponding mock-infected
samples were used for comparison. Measurements of the
pooled RNA were performed in triplicate using normalization
to the G3PDH gene. Data are given as mean values. Primer
sequences were retrieved by BLAST (basic local alignment
Table 1
mRNA transcript expression in microarray
Time course Cytokines Accession number 4 hours pi 1 day pi 7 days pi
3 time points IFN-γ X01992 +++ ++ +
2 time points IL-5 X04688 +++ + -
IL-1-β K02770 - + +
IL-10 M57627 - + +
TGF-β-2 M19154 - + +
1 time point TNF-α X01394 +++ - -
LIF X13967 +++ - -
IL-4 M13982 +++ - -
IL-6 X04602 +++ - -
IL-15 U14407 + - -
IL-16 M90391 + - -
IL-17 (CTLA8) U32659 +++ - -
IL-18 D49950 +++ - -
IL-1-α X02851 - + -
IL-3 M14743 - + -
IL-9 X17543 - + -
IL-11 M57765 - + -
TGF-β-1 X02812 - - +
The table shows mRNA transcripts encoding for cytokines as found to be expressed by microarray in Chlamydia trachomatis-infected human 
monocytes over a time course of up to 7 days. Signal intensity is given as fold of expression as compared with the mock-infected probe. Fold of 
expression for microarray as well as for reverse transcription-polymerase chain reaction data is indicated by '-' (less than 2), '+' (more than or equal 
to 2 and less than 10), '++' (more than or equal to 10 and less than 100), and '+++' (more than or equal to 100). Gene expression was studied at 
three different time points: 4 hours pi indicates the very early phase of active infection, whereas day 1 corresponds to a transition (that is, the 
beginning of growth arrest) and day 7 represents persistent infection. IFN, interferon; IL, interleukin; LIF, leukemia inhibitory factor; pi, post-
infection; TGF, transforming growth factor; TNF, tumor necrosis factor.Arthritis Research & Therapy    Vol 9 No 3    Schrader et al.
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search tool) search and obtained from MWG-Biotech AG
(Ebersberg, Germany). They are given as follows:
Macrophage inflammatory protein-1-alpha (MIP-1-α): sense
5'-CCGACCGCCTGCTGCTTCA-3', antisense 5'-
CTGCCGGCTTCGCTTGGTTAG-3'; MIP-1-beta (MIP-1-β):
sense 5'-CACCGCCTGCTGCTTTTCT-3', antisense 5'-
GACTTGCTTGCTTCTTTTGGTT-3'; interleukin-2 receptor-
gamma (IL-2R-γ): sense 5'-CACTGGGGGAGCAATACT-
TCAAAA-3', antisense 5'-GGGGCATCGTCCGTTCC-3'.
All followed procedures have been approved by the local eth-
ics committee of the Hannover Medical School.
Results
Gene expression analysis of Chlamydia trachomatis-
infected monocytes by microarray
Three time points pi were analyzed. Of the 159 genes encod-
ing cytokines, chemokines, and their receptors, 15 (9%) were
expressed at 4 h pi, 17 (11%) at 1 d pi, and 12 (8%) at 7 d pi.
Among them were four genes found to be differentially
expressed at all three time points: interferon-gamma (IFN-γ),
MIP-1-α, MIP-1-β, and IL-2R-γ. Apart from genes confirming
the monocytic origin of the samples, we identified several
interferon-related transcripts. Data are given in Table 1. Ten
mRNA transcripts were induced exclusively in early infection at
4 h pi. The highest factors of regulation compared to the
corresponding mock-infected monocytes were observed at 4
h pi for IL-6, tumor necrosis factor-alpha (TNF-α), small induc-
Table 2
mRNA transcript expression in microarray
Time course Cytokines Accession number 4 hours pi 1 day pi 7 days pi
3 time points MIP-1-α (CCL3) M23452 ++ (++) + (+) + (++)
MIP-1-β (CCL4) J04130 + (++) + (+) + (++)
2 time points IL-8 (CXCL8) Y00787 - + +
1 time point SCYA-1 (CCL1) M57502 +++ - -
BCA-1 (CXC) AJ002211 - + -
MIG (CXCL9) X72755 - ++ -
IP-10 (CXCL10) X02530 - ++ -
MCP-1 (CCL2) M24545 - - +
MIP-2-α (CXCL2) X53799 - - +
The table shows mRNA transcripts encoding for chemokines as found to be expressed by microarray in Chlamydia trachomatis-infected human 
monocytes over a time course of up to 7 days. Microarray ratios of MIP-1-α and MIP-1-β were confirmed by quantitative real-time reverse 
transcription-polymerase chain reaction (noted in parentheses) (see Figures 1–3). Fold of expression for microarray as well as for reverse 
transcription-polymerase chain reaction data is indicated by '-' (less than 2), '+' (more than or equal to 2 and less than 10), '++' (more than or 
equal to 10 and less than 100), and '+++' (more than or equal to 100). Gene expression was studied at three different time points: 4 hours pi 
indicates the very early phase of active infection, whereas day 1 corresponds to a transition (that is, the beginning of growth arrest) and day 7 
represents persistent infection. BCA, B-cell-attracting chemokine; IL, interleukin; IP, interferon inducible protein; MCP, monocyte chemotactic 
protein; MIG, monokine induced by gamma-interferon; MIP, macrophage inflammatory protein; SCYA, small inducible cytokine.
Table 3
mRNA transcript expression in microarray
Time course Receptors Accession number 4 hours pi 1 day pi 7 days pi
3 time points IL-2R-γ D11086 + (+) + (-) + (+)
1 time point IL-2R-β (CD122) M26062 + - -
IL-5R-α (CD125) M75914 - + -
TNFR M32315 - - +
The table shows mRNA transcripts encoding for cytokine and chemokine receptors as found to be expressed by microarray in Chlamydia 
trachomatis-infected human monocytes over a time course of up to 7 days. Microarray ratios of interleukin-2 receptor-gamma (IL-2R-γ) were 
confirmed by quantitative real-time reverse transcription-polymerase chain reaction (noted in parentheses) (see Figures 1–3). Fold of expression 
for microarray as well as for reverse transcription-polymerase chain reaction data is indicated by '-' (less than 2), '+' (more than or equal to 2 and 
less than 10), '++' (more than or equal to 10 and less than 100), and '+++' (more than or equal to 100). Gene expression was studied at three 
different time points: 4 hours pi indicates the very early phase of active infection, whereas day 1 corresponds to a transition (that is, the beginning 
of growth arrest) and day 7 represents persistent infection. IL-5R-α, interleukin-5 receptor-alpha; TNFR, tumor necrosis factor receptor.Available online http://arthritis-research.com/content/9/3/R54
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ible cytokine A1 (SCYA1, now termed CCL1), IL-4, IL-18, and
IL-17. Eight mRNA transcripts were identified to be exclusively
differentially regulated after 1 d. IL-5 was expressed at both
time points (4 h and 1 d pi), showing a decreasing level of
expression with ongoing infection. Four genes were induced
exclusively in persistent infection (7 d pi): transforming growth
factor-beta-1 (TGF-β-1), monocyte chemotactic protein-1
(MCP-1), MIP-2-α, and TNF receptor (TNFR). In general, most
of the expression levels at 1 d and 7 d pi were clearly lower as
compared with 4 h pi. Apart from IFN-γ, all transcripts found to
be induced at all three time points of infection by the microar-
ray analysis (MIP-1-α, MIP-1-β, and IL-2R-γ) were subjected to
quantitative RT-PCR in order to confirm their level of expres-
sion (Figures 1, 2, 3).
To test whether chlamydial lipopolysaccharide (LPS) or other
cell-wall components might have an effect on gene induction,
we performed RT-PCR measurements on the selected genes
(MIP-1-α, MIP-2-β, and IL-2R-γ) using both UV irradiation-
inactivated and heat-inactivated C. trachomatis-infected
monocytes. For this purpose, chlamydial EBs were treated
with UV light for 1 hour (Stratalinker™; Stratagene, La Jolla,
CA, USA) or attended to heat at 100°C for 20 minutes. For
each sample, a control experiment was performed. Taken
together, the overall level of MIP-1-α, MIP-1-β, and IL-2R-γ
induction did not vary substantially for viable, UV-irradiated,
and heat-inactivated C. trachomatis, respectively. However,
there was an increase in expression for MIP-1-α in monocytes
incubated with UV-inactivated Chlamydia (slight increase at 4
h and 1 d pi and a stronger increase on 7 d pi; data not
shown), indicating that chlamydial LPS or other components
of the cell wall might be relevant for the observed gene
induction.
Discussion
In Chlamydia-induced arthritis, microbial survival within mono-
cytes as the primary synovial host cells leads to a persistent
host-bacterial interaction that determines the pathogenesis of
the arthritis. Several studies have shown that gene expres-
Figure 1
mRNA transcripts constantly expressed over the course of 4 hours by microarray and reverse transcription-polymerase chain reaction (RT-PCR) mRNA transcripts constantly expressed over the course of 4 hours by microarray and reverse transcription-polymerase chain reaction (RT-PCR). 
Signal intensity (SI) ratios of microarray (open bars) and gene expression levels as measured by quantitative real-time RT-PCR (hashed bars) of three 
mRNA transcripts encoding for macrophage inflammatory protein (MIP)-1-α, MIP-1-β, and interleukin-2 receptor-gamma (IL-2R-γ) expressed at 4 
hours post-infection (4 h pi). For both experiments, Chlamydia trachomatis-infected monocytes were used and compared with their mock-infected 
probes.
Figure 2
mRNA transcripts constantly expressed over the course of 1 day by microarray and reverse transcription-polymerase chain reaction (RT-PCR) mRNA transcripts constantly expressed over the course of 1 day by microarray and reverse transcription-polymerase chain reaction (RT-PCR). Sig-
nal intensity (SI) ratios of microarray (open bars) and gene expression levels as measured by quantitative real-time RT-PCR (hashed bars) of three 
mRNA transcripts encoding for macrophage inflammatory protein (MIP)-1-α, MIP-1-β, and interleukin-2 receptor-gamma (IL-2R-γ) expressed at 1 day 
post-infection (1 d pi). For both experiments, Chlamydia trachomatis-infected monocytes were used and compared with their mock-infected probes.Arthritis Research & Therapy    Vol 9 No 3    Schrader et al.
Page 6 of 8
(page number not for citation purposes)
sions of both the host and the pathogen in ReA are signifi-
cantly altered. In particular, investigations of persistently
infected human monocytes have shown aberrant chlamydial
gene expression such as downregulation of omp1, upregula-
tion of hsp60, and changes in chlamydial DNA replication, as
well as production of chlamydial LPS and prostaglandin E2
[14-16].
As for the host response, cytokines and chemokines have
aroused increasing interest in ReA due to their pathogenic role
in joint inflammation and as potential targets for anti-cytokine
therapy. In an elegant attempt to define the gene expression of
the host response by human macrophages to a wide range of
bacterial stimuli, shared and pathogen-specific macrophage
activation programs have been identified [17]. Among the
cytokines/chemokines detected in both our study and other
studies were IL-6, IL-8, interferon inducible protein-10, MCP-
1, MIP-1-α, MIP-1-β, and MIP-2-α. In another study, the per-
sisting organism, Mycobacterium tuberculosis, led to a repres-
sion of IL-12, which is known to be critical for host defense
mechanisms involved not only in tuberculosis but also in ReA
[18]. Interestingly, IL-12 was not differentially expressed in our
study, possibly accounting for the inability of the monocytes to
eliminate  C. trachomatis and thus enhancing persistent
infection.
Gene expression studies on C. trachomatis-infected human
HeLa cells and a monomyeloblastic cell line THP-1 for up to
48 hours revealed the expression of a variety of inflammatory
genes:  IL-6,  IL-8,  IL-11,  MIP-2-α, and leukemia inhibitory
factor (LIF) [9,19] as well as MCP-1, TNF-α, and TNFR [20].
These transcripts were also upregulated in our study, possibly
indicating a typical chlamydial activation program of human
monocytes.
The highest ratios and numbers of cytokine genes are induced
in the early, active infective state, in which C. trachomatis is at
the beginning of the replication cycle and metabolically active
(4 h). One can speculate that this is due to an activation of Toll-
like receptors (TLRs) such as TLR-4 or TLR-2 by chlamydial
LPS or hsp [21]. The time point day 1 can be seen as a phase
of transition indicating the beginning of growth arrest, with the
majority of EBs being internalized. This corresponds to our
finding of an overall normalizing gene expression compared
with mock-infected cells. Finally, day 7 reflects a definite per-
sistent infective state, possibly corresponding to the absence
of TLR activation and to a continuous activation of a smaller
subset of host cell genes, such as IL-8, by chlamydial effector
molecules resembling the situation within the joint, but this
assumption is highly speculative. At this time point, monocytes
show a propensity to express transcripts encoding cytokines
of a Th2- and Th3-like type of response, such as TGF-β, indi-
cating that an anti-inflammatory or regulatory, rather than a pro-
inflammatory, response is dominating in persistence as
opposed to a more Th1-like response in active infection.
As to genes encoding chemokines and receptors, the expres-
sion pattern is more heterogenous (that is, their numbers and
ratios are not decreasing in persistent infection). Two
chemokines (MIP-1-α and MIP-1-β) and one receptor (IL-2R-
γ) are upregulated in active as well as in persistent infection,
supporting the notion that these chemokines belong to a
shared activation program as described by Nau and
colleagues [17]. IL-2R-γ expression in monocytes is known to
be induced by the likewise constantly expressed IFN-γ. Low
serum levels of both IFN-γ and IL-2R have been associated
with an unfavorable and chronic course of ReA [22,23], indi-
cating that expression of these genes in Chlamydia-infected
monocytes contributes to an apparently hampered elimination
of the pathogen.
Sustained expression over the course of 7 days of the mRNA
encoding the chemokine IL-8 as a potential pro-inflammatory
mediator in ReA is also found by microarray in C. trachomatis-
infected THP-1 cells, in human monocytes on the protein level,
as well as in a co-culture model using HeLa/THP-1 cells
Figure 3
mRNA transcripts constantly expressed over the course of 7 days by microarray and reverse transcription-polymerase chain reaction (RT-PCR) mRNA transcripts constantly expressed over the course of 7 days by microarray and reverse transcription-polymerase chain reaction (RT-PCR). Sig-
nal intensity (SI) ratios of microarray (open bars) and gene expression levels as measured by quantitative real-time RT-PCR (hashed bars) of three 
mRNA transcripts encoding for macrophage inflammatory protein (MIP)-1-α, MIP-1-β, and interleukin-2 receptor-gamma (IL-2R-γ) expressed at 7 
days post-infection (7 d pi). For both experiments, Chlamydia trachomatis-infected monocytes were used and compared with their mock-infected 
probes.Available online http://arthritis-research.com/content/9/3/R54
Page 7 of 8
(page number not for citation purposes)
[21,24] (unpublished data). IL-8, accounting for attraction of
polymorphonuclear neutrophils, is part of a general macro-
phage activation program [17]. However, it also seems to play
a prominent role as a pro-inflammatory mediator in the acute
ReA phase and might contribute to persistence by sustaining
an inflammatory state, but this is speculative at the moment
and needs to be confirmed by further investigations.
The limitations of our study should also be mentioned here.
They constitute the small number of arrays performed and
genes subjected to RT-PCR and the fact that the mRNA, but
not the protein level was investigated. In addition, we cannot
exclude the possibility that expression of particular transcripts
such as IFN-γ is derived by cells other than mononuclear cells
even though the majority of mRNA clearly verifies the mono-
cytic origin of the primary culture.
Conclusion
This study is the first comprehensive in vitro analysis on the
induction of gene expression in C. trachomatis-infected
human monocytes over an extended time course of up to 7
days. We show that several transcripts encoding cytokines
can be identified exclusively as differentially regulated in active
versus persistent infection. However, genes encoding one
cytokine (IFN-γ), two chemokines (MIP-1-α and MIP-1-β), and
one receptor (IL-2R-γ) are constantly upregulated during the
observed period of infection.
The present findings have several implications with regard to
the pathogenesis and therapy of ReA. In our study on C. tra-
chomatis-infected human monocytes, as well as in that of Ren
and colleagues [20] on C. trachomatis-infected monocytic
THP-1 cells, gene expressions of inflammatory transcripts
such as TNF-α, IL-1b, IL-8, MCP-1, MIP-1-α, MIP-1-β, and
TNFR were observed. In addition, the present study as well as
the one by Hess and colleagues [9] on human HeLa cells
detected genes encoding IL-8, IL-11, LIF, and MIP-2-α, possi-
bly indicating a typical chlamydial gene expression profile.
Besides, the continuous expression of inflammatory mediators
on a lower level seems to mirror the persistent infection of ReA
represented by intracellular aberrant forms of the bacteria.
Genes whose expression potentially indicates persistent
infection are TGF-β-1, MCP-1, MIP-2-α, and TNFR.
Persistent infection causes a clinical and therapeutic problem
that requires the development of new treatment strategies.
Gene and protein expression studies might enable the identi-
fication of therapeutic targets that, when stimulated or
blocked, can lead to bacterial elimination. In addition, these
mediators may be used as markers to monitor treatment or,
preferably, to ensure therapeutic success.
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